As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...
Objective: To assess health care practitioners' ability to correctly measure the QT interval, and to identify factors and medications that may increase the risk of QT-interval prolongation and ...
Having access to less intrusive QT interval measurement with flexibility around the time and place of the appointment is important 3.1 Psychiatric service user experts explained that it is important ...
AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...
AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can ...
In this survey of health care practitioners' knowledge of the QT interval, we found that an appreciable number of health care practitioners cannot correctly measure the QT interval and cannot identify ...
This section describes the evidence gaps, why they need to be addressed and their relative importance for future committee decision making. The committee will not be able to make a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results